How can companies adapt their single evidence package at launch into multiple, tailored versions for HTAs that vary across different countries and regions?
Cristiana Toader
Advertisement
Cristiana Toader is Manager at Executive Insight.
Articles by Cristiana Toader
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
Texas Files to Prevent Kenvue Dividend Payment
3
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
4
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
5
